These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8141667)

  • 1. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei.
    Nikawa H; Samaranayake LP; Tenovuo J; Pang KM; Hamada T
    Arch Oral Biol; 1993 Dec; 38(12):1057-63. PubMed ID: 8141667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans.
    Samaranayake YH; Samaranayake LP; Wu PC; So M
    APMIS; 1997 Nov; 105(11):875-83. PubMed ID: 9393559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungicidal effect of human lactoferrin against Candida albicans.
    Soukka T; Tenovuo J; Lenander-Lumikari M
    FEMS Microbiol Lett; 1992 Jan; 69(3):223-8. PubMed ID: 1555756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro.
    Nikawa H; Samaranayake LP; Hamada T
    Arch Oral Biol; 1995 Jun; 40(6):581-4. PubMed ID: 7677606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Candida species to lactoferrin.
    Xu YY; Samaranayake YH; Samaranayake LP; Nikawa H
    Med Mycol; 1999 Feb; 37(1):35-41. PubMed ID: 10200932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
    Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
    Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
    Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
    J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal effects of lysozyme and lactoferrin against genetically similar, sequential Candida albicans isolates from a human immunodeficiency virus-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Pow EH; Beena VT; Yeung KW
    J Clin Microbiol; 2001 Sep; 39(9):3296-302. PubMed ID: 11526166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential fungicidal effect of voriconazole against Candida spp.
    Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
    Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lactoferrin and iron on the growth of human pathogenic Candida species.
    Al-Sheikh H
    Pak J Biol Sci; 2009 Jan; 12(1):91-4. PubMed ID: 19579926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary lactoferrin in HIV-infected children: correlation with Candida albicans carriage, oral manifestations, HIV infection and its antifungal activity.
    Alves TP; Simões AC; Soares RM; Moreno DS; Portela MB; Castro GF
    Arch Oral Biol; 2014 Aug; 59(8):775-82. PubMed ID: 24837476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity.
    Viejo-Díaz M; Andrés MT; Fierro JF
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1242-8. PubMed ID: 15047526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel synthetic anti-fungal tripeptide effective against Candida krusei.
    Gill K; Kumar S; Xess I; Dey S
    Indian J Med Microbiol; 2015; 33(1):110-6. PubMed ID: 25560012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Brief Exposure to Lysozyme and Lactoferrin on Pathogenic Attributes of Oral Candida.
    Ellepola ANB; Khan ZU
    Int Dent J; 2024 Oct; 74(5):1161-1167. PubMed ID: 38749888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PgTeL, the lectin found in Punica granatum juice, is an antifungal agent against Candida albicans and Candida krusei.
    da Silva PM; de Moura MC; Gomes FS; da Silva Trentin D; Silva de Oliveira AP; de Mello GSV; da Rocha Pitta MG; de Melo Rego MJB; Coelho LCBB; Macedo AJ; de Figueiredo RCBQ; Paiva PMG; Napoleão TH
    Int J Biol Macromol; 2018 Mar; 108():391-400. PubMed ID: 29225175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH; Ye J; Yau JY; Cheung BP; Samaranayake LP
    J Clin Microbiol; 2005 Feb; 43(2):818-25. PubMed ID: 15695686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant Candida albicans clinical isolate.
    Curvelo JAR; Moraes DC; Anjos CAD; Portela MB; Soares RMA
    An Acad Bras Cienc; 2019; 91(1):e20180045. PubMed ID: 30994755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.